SEARCH

SEARCH BY CITATION

References

  • 1
    Siegel JM (2004) The neurotransmitters of sleep. J Clin Psychiatry 65 (Suppl. 16), 47.
  • 2
    Jones BE (2003) Arousal systems. Front Biosci 8, 438451.
  • 3
    Jones BE (2004) Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog Brain Res 145, 157169.
  • 4
    Gerashchenko D, Okano Y, Urade Y, Inoue S & Hayaishi O (2000) Strong rebound of wakefulness follows prostaglandin D2- or adenosine A2a receptor agonist-induced sleep. J Sleep Res 9, 8187.
  • 5
    Greene R & Siegel J (2004) Sleep: a functional enigma. Neuromolecular Med 5, 5968.
  • 6
    Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437451.
  • 7
    Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S & Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365376.
  • 8
    de Lecea L & Sutcliffe JG (2005) The hypocretins and sleep. FEBS J 272, 56755688.
  • 9
    Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J, Weaver DR, Leslie FM & Zhou QY (2002) Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417, 405410.
  • 10
    de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR, Henriksen SJ & Sutcliffe JG (1996) A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381, 242245.
  • 11
    Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L & Civelli O (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43, 487497.
  • 12
    van der Werf YD, Witter MP & Groenewegen HJ (2002) The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Rev 39, 107140.
  • 13
    Pare D, Quirk GJ & Ledoux JE (2004) New vistas on amygdala networks in conditioned fear. J Neurophysiol 92, 19.
  • 14
    N'junge K & Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38, 6367.
  • 15
    Hascoet M & Bourin M (1998) A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 60, 645653.
  • 16
    Paine TA, Jackman SL & Olmstead MC (2002) Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 13, 511523.
  • 17
    Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P et al. (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96, 1091110916.
  • 18
    Simon P, Panissaud C & Costentin J (1994) The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine. Psychopharmacology 114, 597600.
  • 19
    Chaouloff F, Durand M & Mormede P (1997) Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav Brain Res 85, 2735.
  • 20
    Paxinos G & Watson C (1997) The Rat Brain in Stereotaxic Coordinates. Compact 3rd edn. Academic Press, San Diego, CA.